Actively Recruiting
A Single-center, Open-label, Exploratory Clinical Trial to Evaluate the Safety and Efficacy of a Statics Electricity Generator for Electric Stimulation Home Use (CGM MEPC-2401) for Improving Blood Circulation
Led by Ceragem Clinical Inc. · Updated on 2026-03-03
40
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the safety and effectiveness of a static electricity generator device called the Ceragem Celtron Circulation Chair (CGM MEPC-2401) for improving blood circulation in healthy adults aged 19 to 65 years. The study is an open-label, exploratory clinical trial conducted at a single center to assess how this personal electro-potential generator affects blood flow and related parameters. Participants will use the investigational device, the Ceragem Celltron Circulation Chair, for a 30-minute session during which the device applies electric stimulation aimed at enhancing blood circulation. The trial focuses on measuring changes immediately after the application of the device, without any placebo comparison or blinding. During the study, researchers will measure blood flow changes in the dorsal metacarpal vein, capillary diameter, oxygen saturation, and various blood biomarkers before and immediately after the 30-minute device application. Participants will undergo hematology testing and other evaluations to monitor safety and efficacy. The trial will include healthy volunteers with specific body mass index limits and will last through the treatment and immediate assessment period.
CONDITIONS
Brief Title
Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged between 19 and 65 years
- Body mass index (BMI) of 30.0 kg/m² or less
- No abnormal findings on hematology tests (CBC)
You will not qualify if you...
- Uncontrolled hypertension despite medication (systolic blood pressure 6150 mmHg or diastolic blood pressure 6100 mmHg at rest)
- Use of assistive medical devices such as pacemakers, artificial joints, stents, or prostheses
- History of seizure disorders, loss of consciousness, or high risk of electric shock due to such conditions
- Presence of ventricular arrhythmias or neurological disorders such as diabetic neuropathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single 30-minute application
Participants use the Ceragem Celltron Circulation Chair (CGM MEPC-2401) device at home to improve blood circulation.
1 visit to apply the device
Trial Site Locations
Total: 1 location
1
Wonju Severance Christian Hospital
Wŏnju, South Korea
Actively Recruiting
Research Team
M
Myeongbae Shin, Researcher
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here